Gamal Thabet
Assistant Professor of Clinical pathology, National Cancer Institute
6 October city (email)
N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia
- Citation:
- Kame, A., G. Thabet, and H. S. Moussa, "N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia", Tumor Biology, vol. 36(8), 2015.